companydata.dkcompanydata.dk

Rangers Pharmaceutical A/S: Financial statements 2023

CVR: 40381015

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

Rangers Pharmaceutical A/S (CVR 40381015) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -232,315 and a net result of DKK 1,244,777 compared with DKK -53,111,223 the year before. Equity in the 2023 report amounted to DKK -52,399,418.

Gross Profit
DKK -232,315
Profit/Loss
DKK 1,244,777
Equity
DKK -52,399,418
Total Assets
DKK 421,061

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023--232K1.2M-52.4M-
2022--1.1M-53.1M-53.6M-
2021--2.7M-2.7M-533K0
2020--302K-4.1M-829K1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

Dany Vaiman joins the board of Rangers Pharmaceutical A/SNov 7, 2023

As of November 7, 2023, Dany Vaiman has joined the board of directors of Rangers Pharmaceutical A/S.

Michael James Rank joins the board of Rangers Pharmaceutical A/SNov 7, 2023

As of November 7, 2023, Michael James Rank has joined the board of directors of Rangers Pharmaceutical A/S.

Farhan Lalani leaves the board of Rangers Pharmaceutical A/SNov 7, 2023

As of November 7, 2023, Farhan Lalani has left the board of directors of Rangers Pharmaceutical A/S.

Selcuk Copkayaoglu leaves the board of Rangers Pharmaceutical A/SNov 7, 2023

As of November 7, 2023, Selcuk Copkayaoglu has left the board of directors of Rangers Pharmaceutical A/S.

Rangers Pharmaceutical A/S appoints new auditorOct 1, 2023

As of October 1, 2023, Grant Thornton, Godkendt Revisionspartnerselskab has been appointed auditor of Rangers Pharmaceutical A/S.

Auditor steps down at Rangers Pharmaceutical A/SOct 1, 2023

As of October 1, 2023, Kvist & Jensen Statsautoriseret Revisionspartnerselskab has stepped down as auditor of Rangers Pharmaceutical A/S.

Rangers Pharmaceutical A/S: The 2022 annual report is outJun 29, 2023

Rangers Pharmaceutical A/S has published its annual report for 2022. Gross profit came to DKK -1,123,696, and the net result was DKK -53,111,223.

About Rangers Pharmaceutical A/S

Rangers Pharmaceutical A/S is a Danish company of the type Aktieselskab based in København K, founded in 2019. The company is in liquidation. The company is registered under the industry Dyrkning af krydderiplanter, aromaplanter og lægeplanter. The management consists of Niels Løber. The company is owned by Klokken Aarhus Inc.. The company has 1 employee (2019). In 2025, the company reported a gross profit of DKK -265,330 and a net result of DKK -265,257 compared with DKK 1,641,287 the year before. Equity in the 2025 report amounted to DKK 101,092.

Source: annual report 2025, Danish Business Authority

Other financial years